https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:53996 Wed 28 Feb 2024 16:39:56 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:29868 Wed 15 Dec 2021 16:08:58 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:47175 I² statistic. Meta-analyses employing a fixed effects model were also applied as an additional measure of sensitivity. Results: A total of 27 studies were included which reported on fatherhood after treatment for TC. A meta-analysis of included studies with subgroup analysis was conducted. Subgroup analysis, for the combined studies, indicated an overall pooled pregnancy rate of 22% (95% confidence intervals [CI]: 0.21–0.23; I² = 98.1%) for couples who conceived after TC. Of those couples that became pregnant, 11% (95% CI: 0.07–0.16; I² = 8.5%) experienced a miscarriage. Fatherhood was experienced by 37% (95% CI: 0.35–0.39; I² = 98.1%) of males following treatment for TC. Conclusions: Male cancer patients should be offered discussions, information, and counseling regarding the impact that TC treatment can have on fertility. Furthermore, sperm banking must be recommended to all patients before starting treatment.]]> Wed 14 Dec 2022 15:56:22 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:15133 Wed 11 Apr 2018 14:23:25 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:51843 Thu 21 Sep 2023 09:27:16 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:20442 Sat 24 Mar 2018 08:06:54 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:46738 Mon 10 Jul 2023 13:53:20 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:51353 Fri 01 Sep 2023 13:35:36 AEST ]]>